Literature DB >> 11657424

Wrestling with the future: should we test children for adult-onset genetic conditions?

Cynthia B Cohen.   

Abstract

Genetics professionals have been reluctant to test children for adult-onset conditions because they believe this would create psychosocial harm to children not counterbalanced by significant benefits. An additional concern they express is that such testing would violate the autonomy of these children as adults. Yet weighing the harms and benefits of such testing results in a draw, with no substantial harms proven. Moreover, such testing can enhance, rather than violate the adult autonomy of these children. In deciding whether to proceed with predictive testing of children, parents, mature children, and health care professionals should consider a complex of factors relevant to the particular child. The importance of these factors will vary depending on the condition at issue, the age and stage of development of the child, family dynamics, and the concerns, values, and objectives of the parents and mature child. The final decision whether to test a child for an adult-onset condition should rest with the parents and the mature child.

Entities:  

Keywords:  Analytical Approach; Genetics and Reproduction

Mesh:

Year:  1998        PMID: 11657424     DOI: 10.1353/ken.1998.0014

Source DB:  PubMed          Journal:  Kennedy Inst Ethics J        ISSN: 1054-6863


  12 in total

1.  Genetic testing in adoption. The American Society of Human Genetics Social Issues Committee and The American College of Medical Genetics Social, Ethical, and Legal Issues Committee.

Authors: 
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

2.  Firing up the nature/nurture controversy: bioethics and genetic determinism.

Authors:  I de Melo-Martín
Journal:  J Med Ethics       Date:  2005-09       Impact factor: 2.903

3.  Questioning the consensus: managing carrier status results generated by newborn screening.

Authors:  Fiona Alice Miller; Jason Scott Robert; Robin Z Hayeems
Journal:  Am J Public Health       Date:  2008-12-04       Impact factor: 9.308

Review 4.  A systematic review of the effects of disclosing carrier results generated through newborn screening.

Authors:  R Z Hayeems; J P Bytautas; F A Miller
Journal:  J Genet Couns       Date:  2008-10-28       Impact factor: 2.537

5.  Presymptomatic genetic testing for hereditary cancer in young adults: a survey of young adults and parents.

Authors:  Lea Godino; Daniela Turchetti; Leigh Jackson; Catherine Hennessy; Heather Skirton
Journal:  Eur J Hum Genet       Date:  2018-10-04       Impact factor: 4.246

Review 6.  Can children and young people consent to be tested for adult onset genetic disorders?

Authors:  D L Dickenson
Journal:  BMJ       Date:  1999-04-17

Review 7.  Controversies in communication of genetic screening results for cancer: a report from the American Society of Preventive Oncology's Screening Special Interest Group (ASPO's 33rd Annual Meeting, March 8 to 10, 2009, Tampa, Florida).

Authors:  Linda Patrick-Miller; Angela R Bradbury; Mary Beth Terry
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

8.  Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS).

Authors:  Beth N Peshkin; Tiffani A DeMarco; Judy E Garber; Heiddis B Valdimarsdottir; Andrea F Patenaude; Katherine A Schneider; Marc D Schwartz; Kenneth P Tercyak
Journal:  J Pediatr Psychol       Date:  2008-04-01

9.  Genetic testing of children for familial cancers: a comparative legal perspective on consent, communication of information and confidentiality.

Authors:  Roy Gilbar
Journal:  Fam Cancer       Date:  2009-07-17       Impact factor: 2.375

Review 10.  Molecular genetic testing and the future of clinical genomics.

Authors:  Sara Huston Katsanis; Nicholas Katsanis
Journal:  Nat Rev Genet       Date:  2013-06       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.